Trade Summary

6 days ago, TABUTEAU HERRIOT, serving as Chief Executive Officer at Axsome Therapeutics, Inc. (AXSM), sold 49,664 shares at $212.19 per share, for a total transaction value of $10,538,305.04. Following this transaction, TABUTEAU HERRIOT now holds 7,229 shares of AXSM.

This sale represents a 87.29% decrease in TABUTEAU HERRIOT's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 7:00 PM ET, 2 days after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.